Vertex to Present at the UBS Healthcare Conference on May 19
May 13 2015 - 4:01PM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that Jeffrey Leiden, M.D., Ph.D., Chairman, President
& CEO of Vertex will present at the UBS Healthcare Conference
in New York, NY on Tuesday, May 19th at 11:00 a.m. ET.
The audio portion of management’s remarks from the conference
will be accessible live through Vertex’s website at www.vrtx.com in
the “Investors” section under the “Events and Presentations” page.
A replay of the conference webcast will be archived on the
company’s website.
About Vertex
Vertex is a global biotechnology company that aims to discover,
develop and commercialize innovative medicines so people with
serious diseases can lead better lives. In addition to our clinical
development programs focused on cystic fibrosis, Vertex has more
than a dozen ongoing research programs aimed at other serious and
life-threatening diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has research
and development sites and commercial offices in the United States,
Europe, Canada and Australia. For five years in a row, Science
magazine has named Vertex one of its Top Employers in the life
sciences. For additional information and the latest updates from
the company, please visit www.vrtx.com.
(VRTX-WEB)
Vertex Pharmaceuticals
IncorporatedInvestors:Michael Partridge,
617-341-6108orKelly Lewis, 617-961-7530
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Sep 2023 to Sep 2024